Age-related changes in parvalbumin-positive interneurons in the striatum, but not in the sensorimotor cortex in dystonic brains of the dtsz mutant hamster

Brain Research

Volumn 1150, Issue 1, 2007, Pages 190-199

  Hamann, Melanie ^a   Richter, Angelika ^a   Meillasson, Florence Vollenweider ^b   Nitsch, Cordula ^b   Ebert, Ulrich ^c  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

^c ABBOTT GMBH AND CO KG   (Germany)

Author keywords

Basal ganglia disorder; Caudate putamen; Dyskinesia; Movement disorder

Indexed keywords

4 AMINOBUTYRIC ACID; BROXURIDINE; MESSENGER RNA; PARVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DYSTONIA; EXTRAPYRAMIDAL SYNDROME; FEMALE; GENE EXPRESSION; INTERNEURON; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSORIMOTOR CORTEX;

AGE FACTORS; AGING; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CORPUS STRIATUM; CRICETINAE; DISEASE MODELS, ANIMAL; DYSTONIA; FEMALE; IN SITU HYBRIDIZATION; INTERNEURONS; MALE; PARVALBUMINS; SEX FACTORS;

ANIMALIA; CRICETINAE;

EID: 34247884250     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.02.074     Document Type: Article

References (55)

1. Alexander G.E., Crutcher M.D., and DeLong M.R. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog. Brain Res. 85 (1990) 119-146
2. Bender R., Hoffmann M.C., Frotscher M., and Nitsch C. Species-specific expression of parvalbumin in the entorhinal cortex of the Mongolian gerbil: dependence on local activity but not extrinsic afferents. Neuroscience 99 3 (2000) 423-431
3. Bennay M., Gernert M., and Richter A. Spontaneous remission of paroxysmal dystonia coincides with normalization of entopeduncular activity in dt(SZ) mutants. J. Neurosci. 21 13 (2001) RC153
4. Bolam J.P., Hanley J.J., Booth P.A., and Bevan M.D. Synaptic organisation of the basal ganglia. J. Anat. 196 Pt. 4 (2000) 527-542
5. Burgunder J., Richter A., and Löscher W. Expression of cholecystokinin, somatostatin, thyrotropin-releasing hormone, glutamic acid decarboxylase and tyrosine hydroxylase genes in the central nervous motor systems of the genetically dystonic hamster. Exp. Brain Res. 129 1 (1999) 114-120
6. Caillard O., Moreno H., Schwaller B., Llano I., Celio M.R., and Marty A. Role of the calcium-binding protein parvalbumin in short-term synaptic plasticity. Proc. Natl. Acad. Sci. U. S. A. 97 24 (2000) 13372-13377
7. Centonze D., Grande C., Usiello A., Gubellini P., Erbs E., Martin A.B., Pisani A., Tognazzi N., Bernardi G., Moratalla R., Borrelli E., and Calabresi P. Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons. J. Neurosci. 23 15 (2003) 6245-6254
8. Collin T., Chat M., Lucas M.G., Moreno H., Racay P., Schwaller B., Marty A., and Llano I. Developmental changes in parvalbumin regulate presynaptic Ca2+ signaling. J. Neurosci. 25 1 (2005) 96-107
9. Cowan R.L., Wilson C.J., Emson P.C., and Heizmann C.W. Parvalbumin-containing GABAergic interneurons in the rat neostriatum. J. Comp. Neurol. 302 2 (1990) 197-205
10. Craver R.D., Duncan M.C., and Nelson J.S. Familial dystonia and choreoathetosis in three generations associated with bilateral striatal necrosis. J. Child Neurol. 11 3 (1996) 185-188
11. DeFelipe J. Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex. J. Chem. Neuroanat. 14 1 (1997) 1-19
12. Fahn S. Medical treatment of dystonia. In: Tsui J.K.C., and Calne D.B. (Eds). Handbook of Dystonia (1995), Marcel Dekker, New York 311-345
13. Fahn S., Bressman S.B., and Marsden C.D. Classification of dystonia. Adv. Neurol. 78 (1998) 1-10
14. French S.J., Hailstone J.C., and Totterdell S. Basolateral amygdala efferents to the ventral subiculum preferentially innervate pyramidal cell dendritic spines. Brain Res. 981 1-2 (2003) 160-167
15. Gernert M., Richter A., and Löscher W. Alterations in spontaneous single unit activity of striatal subdivisions during ontogenesis in mutant dystonic hamsters. Brain Res. 821 2 (1999) 277-285
16. Gernert M., Hamann M., Bennay M., Löscher W., and Richter A. Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia. J. Neurosci. 20 18 (2000) 7052-7058
17. Gernert M., Bennay M., Fedrowitz M., Rehders J.H., and Richter A. Altered discharge pattern of basal ganglia output neurons in an animal model of idiopathic dystonia. J. Neurosci. 22 16 (2002) 7244-7253
18. Gilio F., Curra A., Inghilleri M., Lorenzano C., Suppa A., Manfredi M., and Berardelli A. Abnormalities of motor cortex excitability preceding movement in patients with dystonia. Brain 126 Pt. 8 (2003) 1745-1754
19. Grobin A.C., Heenan E.J., Lieberman J.A., and Morrow A.L. Perinatal neurosteroid levels influence GABAergic interneuron localization in adult rat prefrontal cortex. J. Neurosci. 23 5 (2003) 1832-1839
20. Hallett M. Physiology of dystonia. Adv. Neurol. 78 (1998) 11-18
21. Hamann M., and Richter A. Effects of striatal injections of GABA(A) receptor agonists and antagonists in a genetic animal model of paroxysmal dystonia. Eur. J. Pharmacol. 443 1-3 (2002) 59-70
22. Hamann M., and Richter A. Striatal increase of extracellular dopamine levels during dystonic episodes in a genetic model of paroxysmal dyskinesia. Neurobiol. Dis. 16 1 (2004) 78-84
23. Hamann M., Sander S.E., and Richter A. Age-dependent alterations of striatal calretinin interneuron density in a genetic animal model of primary paroxysmal dystonia. J. Neuropathol. Exp. Neurol. 64 9 (2005) 776-781
24. Hamann M., Raymond R., Varughesi S., Nobrega J.N., and Richter A. Acetylcholine receptor binding and cholinergic interneuron density are unaltered in a genetic animal model of primary paroxysmal dystonia. Brain Res. 1099 1 (2006) 176-182
25. Jankovic J. Treatment of dystonia. Lancet Neurol. 5 10 (2006) 864-872
26. Kawaguchi Y., Wilson C.J., Augood S.J., and Emson P.C. Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci. 18 12 (1995) 527-535
27. Köhling R., Koch U.R., Hamann M., and Richter A. Increased excitability in cortico-striatal synaptic pathway in a model of paroxysmal dystonia. Neurobiol. Dis. 16 1 (2004) 236-245
28. Koos T., and Tepper J.M. Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nat. Neurosci. 2 5 (1999) 467-472
29. Levy L.M., and Hallett M. Impaired brain GABA in focal dystonia. Ann. Neurol. 51 1 (2002) 93-101
30. Löscher W., Fisher Jr. J.E., Schmidt D., Fredow G., Hönack D., and Iturrian W.B. The sz mutant hamster: a genetic model of epilepsy or of paroxysmal dystonia?. Mov. Disord. 4 3 (1989) 219-232
31. Luk K.C., and Sadikot A.F. GABA promotes survival but not proliferation of parvalbumin-immunoreactive interneurons in rodent neostriatum: an in vivo study with stereology. Neuroscience 104 1 (2001) 93-103
32. Marin O., Anderson S.A., and Rubenstein J.L. Origin and molecular specification of striatal interneurons. J. Neurosci. 20 16 (2000) 6063-6076
33. Middleton F.A., and Strick P.L. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res. Brain Res. Rev. 31 2-3 (2000) 236-250
34. Morin L.P., and Wood R.I. A Stereotaxic Atlas of the Golden Hamster Brain (2001), Academic Press, San Diego
35. Nakano K., Kayahara T., Tsutsumi T., and Ushiro H. Neural circuits and functional organization of the striatum. J. Neurol. 247 Suppl. 5 (2000) V1-V15
36. Nardocci N., Fernandez-Alvarez E., Wood N.W., Spacy S.D., and Richter A. The paroxysmal dyskinesias. In: Guerrini R., Aicardi J., Andermann F., and Hallett M. (Eds). Epilepsy and Movement Disorders (2002), Cambridge Univ. Press, Cambridge 125-139
37. Negoescu A., Labat-Moleur F., Lorimier P., Lamarcq L., Guillermet C., Chambaz E., and Brambilla E. F(ab) secondary antibodies: a general method for double immunolabeling with primary antisera from the same species. Efficiency control by chemiluminescence. J. Histochem. Cytochem. 42 3 (1994) 433-437
38. Nobrega J.N., Gernert M., Löscher W., Raymond R., Belej T., and Richter A. Tyrosine hydroxylase immunoreactivity and [3H]WIN 35,428 binding to the dopamine transporter in a hamster model of idiopathic paroxysmal dystonia. Neuroscience 92 1 (1999) 211-217
39. Nobrega J.N., Raymond R., Barlow K., Hamann M., and Richter A. Changes in AMPA receptor binding in an animal model of inborn paroxysmal dystonia. Exp. Neurol. 176 2 (2002) 371-376
40. Plenz D. When inhibition goes incognito: feedback interaction between spiny projection neurons in striatal function. Trends Neurosci. 26 8 (2003) 436-443
41. Powell E.M., Campbell D.B., Stanwood G.D., Davis C., Noebels J.L., and Levitt P. Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J. Neurosci. 23 2 (2003) 622-631
42. Ramanathan S., Hanley J.J., Deniau J.M., and Bolam J.P. Synaptic convergence of motor and somatosensory cortical afferents onto GABAergic interneurons in the rat striatum. J. Neurosci. 22 18 (2002) 8158-8169
43. Rehders J.H., Löscher W., and Richter A. Evidence for striatal dopaminergic overactivity in paroxysmal dystonia indicated by microinjections in a genetic rodent model. Neuroscience 97 2 (2000) 267-277
44. Richter A. The genetically dystonic hamster: an animal model of paroxysmal dystonia. In: LeDoux M. (Ed). Animal Models of Movement Disorders (2005), Elsevier Academic Press, Amsterdam 459-466
45. Richter A., and Löscher W. Alterations in pharmacological sensitivity of GABAergic but not dopaminergic and glutamatergic systems during ontogenesis in dystonic mutant hamsters. Eur. J. Pharmacol. 231 1 (1993) 111-119
46. Richter A., and Löscher W. Pathophysiology of idiopathic dystonia: findings from genetic animal models. Prog. Neurobiol. 54 6 (1998) 633-677
47. Richter A., and Löscher W. Animal models of paroxysmal dystonia. Adv. Neurol. 89 (2002) 443-451
48. Sander S.E., Hamann M., and Richter A. Age-related changes in striatal nitric oxide synthase-immunoreactive interneurones in the dystonic dtsz mutant hamster. Neuropathol. Appl. Neurobiol. 32 (2006) 74-82
49. Schlösser B., Klausa G., Prime G., and Ten Bruggencate G. Postnatal development of calretinin- and parvalbumin-positive interneurons in the rat neostriatum: an immunohistochemical study. J. Comp. Neurol. 405 2 (1999) 185-198
50. Stumm R.K., Zhou C., Ara T., Lazarini F., Dubois-Dalcq M., Nagasawa T., Hollt V., and Schulz S. CXCR4 regulates interneuron migration in the developing neocortex. J. Neurosci. 23 12 (2003) 5123-5130
51. Tinazzi M., Rosso T., and Fiaschi A. Role of the somatosensory system in primary dystonia. Mov. Disord. 18 6 (2003) 605-622
52. Vitek J.L., and Giroux M. Physiology of hypokinetic and hyperkinetic movement disorders: model for dyskinesia. Ann. Neurol. 47 4 Suppl. 1 (2000) S131-S140
53. Wahnschaffe U., Fredow G., Heintz P., and Löscher W. Neuropathological studies in a mutant hamster model of paroxysmal dystonia. Mov. Disord. 5 4 (1990) 286-293
54. Wichmann T., and DeLong M.R. Functional and pathophysiological models of the basal ganglia. Curr. Opin. Neurobiol. 6 6 (1996) 751-758
55. Xu Q., Cobos I., De La Cruz E., Rubenstein J.L., and Anderson S.A. Origins of cortical interneuron subtypes. J. Neurosci. 24 11 (2004) 2612-2622